Naprogenix has commercialized technology that aims to enable bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's current focus is on non-toxic insecticides, CNS-acting drugs and chemotherapeutic agents.

Naprogenix has commercialized technology that aims to enable bio-prospecting (screening) of Kentucky native plants and mutant plants for molecules that could lead to plant-based medicines and natural insecticides. Founded in 2002, the company's cur...Show all